GreenLight Biosciences- Warrants (30/09/2027) Accounts Payable

The latest accounts payable for GRNAW is $1.1M as of March 2023. That compares with $6M in the prior-year period — down 82.3% year over year. Investors often review this figure alongside GreenLight Biosciences- Warrants (30/09/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, GRNAW's accounts payable moved from $6M to $1.1M — a 82.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GreenLight Biosciences- Warrants (30/09/2027)'s operating scale or balance-sheet position.

A accounts payable figure of $1.1M for GRNAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GRNAW's accounts payable ($1.1M), review year-over-year change from $6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.